Prevalence of chronic kidney disease in an urban Mexican population

Amato, Dante; Álvarez-Aguilar, Cleto; Castañeda-Limones, Rutila; Rodríguez, Ernesto Hernández; Ávila-Díaz, Marcela; Arreola, F.; Gomez, Anel; Ballesteros, Hiram; R, Becerril; Paniagua, Ramón

doi:10.1111/j.1523-1755.2005.09702.x

Cited by 115 publications

(92 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In Mexico, CKD prevalence among the poor is two-to threefold higher than that of the general population, and the etiology is unknown in 30 % of ESRD patients. [23][24][25][26].…”

Section: Ckd In Developing Countriesmentioning

confidence: 99%

Chronic kidney disease in disadvantaged populations

Garcia-Garcia

Jha

2014

Pediatr Nephrol

View full text Add to dashboard Cite

“…In Mexico, CKD prevalence among the poor is two-to threefold higher than that of the general population, and the etiology is unknown in 30 % of ESRD patients. [23][24][25][26].…”

Section: Ckd In Developing Countriesmentioning

confidence: 99%

Chronic kidney disease in disadvantaged populations

Garcia-Garcia

Jha

2014

Pediatr Nephrol

View full text Add to dashboard Cite

“…However, ESRD of unknown origin is one of the most prevalent diagnoses due to a lack of prompt recognition of the disease, and is unclear whether hypertension is a cause or consequence of CKD [20]. Furthermore, a study including 3564 healthy subjects reported a prevalence of deteriorated creatinine clearance <60 mL/min of 37% [21].…”

Section: Chronic Kidney Diseasementioning

confidence: 99%

Fluid Overload in Peritoneal Dialysis

Pazarín-Villaseñor¹,

Yanowsky-Escatell²,

Andrade‐Sierra³

et al. 2018

Chronic Kidney Disease - From Pathophysiology to Clinical Improvements

View full text Add to dashboard Cite

The prevalence of end-stage renal disease (ESRD) has increased globally to 10% due to diabetes mellitus, hypertension, and stroke. When chronic kidney disease (CKD) maintenance therapy fails, patients require renal replacement therapy (RRT) to survive, such as peritoneal dialysis (PD), hemodialysis, and renal transplantation. The most common therapy in Mexico is PD because it is a feasible, low-cost, and easy-to-perform procedure; however, fluid overload is a frequent condition in patients with this RRT modality.The usual adverse comorbidities in patients with PD are cardiovascular diseases (CVD) associated to atherosclerosis, uremia, inflammation, and oxidative stress. Fluid overload is intimately associated to hypertension, left ventricular hypertrophy, heart failure, and worsening of kidney failure, leading to increased hospital admissions, higher cardiovascular mortality, and reduced life expectancy. Two main pathologies are involved in the deterioration of both heart and kidney functions, namely, cardiorenal syndrome and uremic cardiomyopathy. Along with these phenomena, patients in PD with rapid peritoneal transport have reduced ultrafiltration, increased glucose absorption, and albumin loss in the dialysate, which lead to overhydration, hypertension, dyslipidemia, and malnutrition. This review focuses on the clinical, physiological, and biochemical mechanisms involved in fluid overload of patients with CKD undergoing PD.

show abstract

“…Hypertension was present in 25% of the patients with a Ccr Ͻ60 ml/min and in 58% of those with a Ccr Ͻ15 ml/min. Proteinuria was detectable in 8.7% of those with Ccr Ͻ60 ml/min but increased to 12.5% in those with diabetes and hypertension (36). If we extrapolate the values published in the Third National Health and Nutrition Examination Survey (NHANES III) (37) for the population of LA in comparable age groups, there may be 47,000,000 patients with CKD in the region (Table 3).…”

Section: Prevalence Of Ckd Progression Risk Factors In Lamentioning

confidence: 99%

Chronic Kidney Disease in Latin America

Cusumano

Bedat²

2008

Clinical Journal of the American Society of Nephrology

View full text Add to dashboard Cite

Latin America is a conglomerate of adjacent countries that share a Latin extraction and language (Spanish or Portuguese) and exhibit extreme variations in socioeconomic status. End-stage renal disease prevalence and incidence rates have been growing steadily, probably as a result of the increase in life expectancy, aging of the population, a growing epidemic of type 2 diabetes, and a fast epidemiologic transition across the region. Chronic noncommunicable diseases impose an enormous cost, barely supported at present and unlikely afforded by Latin America in the future. National health surveys in Chile, Mexico, and Argentina showed a high prevalence of cardiovascular risk factors. A total of 21% of the Chilean population had a creatinine clearance <80 ml/min. Among the surveyed people, 8.6% of Argentines, 14.2% of Chileans, and 9.2% of Mexicans had proteinuria. There are ongoing national chronic kidney disease detection programs in Brazil, Cuba, Peru, Uruguay, and Venezuela; Argentina, Colombia, Bolivia, Dominican Republic, Guatemala, and Paraguay are still developing them. The prevalence of cardiovascular and renal risk factors is high in Latin America. Data about chronic kidney disease are scarce, but public health awareness is high, evidenced by ongoing or developing chronic kidney disease detection programs. High-risk patients (e.g., those with hypertension or diabetes, elderly) must be studied, using simple determinations such as creatinine and proteinuria. For these programs to succeed, lifestyle changes must be encouraged, and public awareness must be increased through teaching and media-oriented activities.

show abstract

Prevalence of chronic kidney disease in an urban Mexican population

Abstract: Chronic kidney disease prevalence in this population is similar to that seen in industrialized countries. If these figures are similar to those of the entire Mexican population, only l out of 4 patients requiring renal replacement therapy in the country currently has access to it.

Cited by 115 publications

References 29 publications

Chronic kidney disease in disadvantaged populations

Chronic kidney disease in disadvantaged populations

Fluid Overload in Peritoneal Dialysis

Chronic Kidney Disease in Latin America

Contact Info

Product

Resources

About